ASHG 2026 has ended. This guide stays up as the record of who was there. Next: ASHG 2027, Oct 26–30, 2027 in Nashville

University of Alabama at Birmingham at ASHG 2026

Oct 20–24, 2026 Montréal, Canada ~7.5k attendees Website

University of Alabama at Birmingham brings 8 presentations from 5 research groups to ASHG 2026 in Montréal. Its program centres on rare disease, population genetics and computational and clinical approaches to therapeutics. McDonald Laboratory of Integrative 'Omics brings Million Veteran Program studies of hip osteoarthritis, Center for Computational Genomics and Data Science brings genetic modifiers in pulmonary arterial hypertension, and Genomic Medicine & Program for Translational Pharmacogenomics brings pharmacogenomics in clinical care.

OrganizationASHG 2026 Attendance
3 PhD Students · 2 Faculty
McDonald Laboratory of Integrative 'Omicssites.uab.edu/mcdonaldlab/home/people
Dry lab~9 people
Integrates gene, transcript, protein and metabolite data with deep disease phenotyping. Studies COPD, osteoarthritis and joint replacement, including work in the Million Veteran Program.
47 papers since 2024
›
Translational genomics of osteoarthritis in 1,962,069 individuals
Nature, 2025
Sequencing in over 50,000 cases identifies coding and structural variation underlying atrial fibrillation risk
Nature Genetics, 2025
Chronic Obstructive Pulmonary Disease Exacerbations Increase the Risk of Subsequent Cardiovascular Events: A Longitudinal Analysis of the COPDGene Study
Journal of the American Heart Association, 2024
Source: OpenAlex author A5029870208
10 platforms and techniques
›
Analyzes
Electronic health records, Quantitative CT
Techniques
Genetic epidemiology, Statistical genetics, Bioinformatics, Network analysis, Differential expression analysis, qPCR, RNA extraction, Pharmacogenetic enrichment scores
Source: lab pages
Currently hiring
›
“Current openings include post-doctoral, pre-doctoral and student research assistants.”
Source: lab positions page
No funding stated
Poster
Thu Oct 22
4:15 pm
Pathway analysis identified biological mechanisms of hip osteoarthritis in the Million Veteran Program
Collaborators: University of California, Los Angeles
Complex traitsExpression quantitative trait lociGenome-wide association studyTranscriptome
Poster
Fri Oct 23
2:30 pm
Spatial Transcriptomics of Skeletal Muscle in COPD and COPD Cachexia Reveal Dysregulation in Intracellular Communication and Mitochondrial Dysfunction
Collaborators: Harbor–UCLA Medical Center
Spatial transcriptomicsMuscular abnormalitiesComplex diseasesMitochondria
Center for Computational Genomics and Data Sciencesites.uab.edu/cgds
Dry lab~12 people
Analyzes whole genome sequencing, RNA-seq, multi-omic profiling and clinical data with computational genomics tools. Supports rare-disease diagnosis, variant prioritization and precision medicine.
18 papers since 2024
›
An optimized variant prioritization process for rare disease diagnostics: recommendations for Exomiser and Genomiser
Genome Medicine, 2025
Critical assessment of variant prioritization methods for rare disease diagnosis within the rare genomes project
Human Genomics, 2024
Loss of function of FAM177A1, a Golgi complex localized protein, causes a novel neurodevelopmental disorder
Genetics in Medicine, 2024
Source: OpenAlex author A5006311402
Funded by ARPA-H, NIH
›
NIH, Center for Precision Animal Modeling, Grant No. 2U54OD030167-06 · through 2030
“CPAM has received renewed NIH funding (Grant No. 2U54OD030167-06) through 2030”
ARPA-H, Biomedical Data Science · active
“CGDS Awarded ARPA-H Funding as Part of $8.7M UAB-Led Initiative in Biomedical Data Science”
Source: lab pages
11 platforms and techniques
›
Analyzes
whole genome sequencing, RNA-seq, WES, bulk RNA-seq, single-cell atlas, VCF data
Techniques
gene regulatory network analysis, machine learning, systems biology, precision animal modeling, variant prioritization
Source: lab pages
Currently hiring
›
“We are always interested in talking to creative, motivated, and inquisitive individuals at various career stages.”
Source: lab positions page
Genomic Medicine & Program for Translational Pharmacogenomicsidm.uab.edu/cgi-bin/dir/query?key=GPZVFMAH&pop=1
Dry lab
Analyzes genotype, clinical and drug-response data with candidate-gene, genome-wide association and exome approaches. Applies genotype-guided therapy to anticoagulant and antiplatelet response across UAB clinical care.
34 papers since 2024
›
Splenic CD169 + Tim4 + Marginal Metallophilic Macrophages Are Essential for Wound Healing After Myocardial Infarction
Circulation, 2025
Selection, optimization and validation of ten chronic disease polygenic risk scores for clinical implementation in diverse US populations
Nature Medicine, 2024
Advancing genomics to improve health equity
Nature Genetics, 2024
Source: OpenAlex author A5079771081
Funded by National Human Genome Research Institute, State of Alabama
›
National Human Genome Research Institute, SouthEast Regional GEnomic Medicine eConsult Service (SEGEMS) · through February 2028
“a $2.9 million NIH grant awarded to [name], Pharm.D., Ph.D., will expand genomic medicine access through SEGEMS”
State of Alabama, Alabama Genomic Health Initiative · active
“Supported by the State of Alabama and driven by a shared goal to improve health outcomes”
Source: lab pages
4 platforms and techniques
›
Techniques
Candidate-gene analysis, Genotype-guided therapy, Prospective cohorts and randomized clinical trials, Genomic risk scores
Source: lab pages
No openings posted
Poster
Wed Oct 21
2:30 pm
Hugh Kaul Precision Medicine Instituteuab.edu/medicine/pmi/about/leadership-team
Wet + dry lab~27 people
Uses AI, bioinformatics, genomic engineering, lab science and mediKanren to study genetic disorders. Develops therapeutic strategies with patients, families, clinicians and researchers.
24 papers since 2024
›
Large-scale mutational analysis identifies UNC93B1 variants that drive TLR-mediated autoimmunity in mice and humans
The Journal of Experimental Medicine, 2024
Characteristics and determinants of pulmonary long COVID
JCI Insight, 2024
De novo variants in DENND5B cause a neurodevelopmental disorder
The American Journal of Human Genetics, 2024
Source: OpenAlex author A5086121459
Funded by ARPA-H, NIH
›
ARPA-H · active
“PMI also leads ARPA-H initiatives focused on AI-driven data integration, drug repurposing for rare diseases”
NIH · active
“At UAB, Dr. Might's NIH and philanthropically funded research focuses on precision prevention, diagnosis and therapeutics”
Source: lab pages
5 platforms and techniques
›
Analyzes
mediKanren
Techniques
CRISPR-Cas9, Zebrafish models, Genomic engineering, AI-driven drug repurposing
Source: lab pages
No openings posted
Poster
Wed Oct 21
2:30 pm
Near-term Impact of Type 2 Polygenic Risk Score Disclosure on Glycemic Monitoring and Treatment: The Electronic Medical Records and Genomics Study
Collaborators: Icahn School of Medicine at Mount Sinai, University of Washington +6 more
Complex diseasesDiabetesElectronic health recordsPolygenic risk score
Limdi Laboratory
Works in clinical genetics and therapeutics.
2 more presenters — research group not yet identified

Explore the full ASHG 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Montréal. Leave your work email and we’ll be in touch.

Privacy

Download the full ASHG 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at University of Alabama at Birmingham

Tell us what you sell and we’ll find the people at University of Alabama at Birmingham most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction